Related Experiment Video
Updated: Oct 30, 2025

Detection of Inflammasome Activation and Pyroptotic Cell Death in Murine Bone Marrow-derived Macrophages
Published on: May 21, 2018
The Role of Melatonin on NLRP3 Inflammasome Activation in Diseases
Burak Ibrahim Arioz1,2, Emre Tarakcioglu1,2, Melis Olcum1
1Izmir Biomedicine and Genome Center, Dokuz Eylul University Health Campus, 35340 Izmir, Turkey.
Abstract:
NLRP3 inflammasome is a part of the innate immune system and responsible for the rapid identification and eradication of pathogenic microbes, metabolic stress products, reactive oxygen species, and other exogenous agents. NLRP3 inflammasome is overactivated in several neurodegenerative, cardiac, pulmonary, and metabolic diseases. Therefore, suppression of inflammasome activation is of utmost clinical importance. Melatonin is a ubiquitous hormone mainly produced in the pineal gland with circadian rhythm regulatory, antioxidant, and immunomodulatory functions. Melatonin is a natural product and safer than most chemicals to use for medicinal purposes. Many in vitro and in vivo studies have proved that melatonin alleviates NLRP3 inflammasome activity via various intracellular signaling pathways. In this review, the effect of melatonin on the NLRP3 inflammasome in the context of diseases will be discussed.
Insights
Melatonin, a natural hormone, effectively suppresses the overactivated NLRP3 inflammasome, a key player in immune responses and various diseases. This review explores melatonin
Area of Science:
- Immunology
- Neuroscience
- Endocrinology
Background:
- The NLRP3 inflammasome is crucial for innate immunity, detecting pathogens and cellular stress.
- Overactivation of the NLRP3 inflammasome is implicated in diseases like neurodegeneration, cardiac, pulmonary, and metabolic disorders.
- Inhibiting NLRP3 inflammasome activation is a significant therapeutic goal.
Purpose of the Study:
- To review the impact of melatonin on NLRP3 inflammasome activity.
- To discuss the therapeutic potential of melatonin in disease contexts involving NLRP3 inflammasome dysregulation.
Main Methods:
- Literature review of in vitro and in vivo studies.
- Analysis of intracellular signaling pathways affected by melatonin.
- Examination of melatonin's role in disease models.
Main Results:
- Melatonin demonstrates significant ability to alleviate NLRP3 inflammasome activation.
- Evidence suggests melatonin acts through multiple intracellular signaling pathways.
- Melatonin's antioxidant and immunomodulatory properties contribute to its effects.
Conclusions:
- Melatonin is a promising natural compound for modulating NLRP3 inflammasome activity.
- Targeting the NLRP3 inflammasome with melatonin may offer therapeutic benefits for various diseases.
- Further research into melatonin's mechanisms and clinical applications is warranted.
Related Concept Videos
NF-κB-dependent Signaling Pathway
NF-κB-dependent Signaling Mechanism
The...
The Intrinsic Apoptotic Pathway
T Cell Types and Functions
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
Inflammation
Circadian Rhythms and Gene Regulation
Management of Insomnia

